Efficacy of Fremanezumab in Migraine Patients Who Have Failed at Least One Prior Migraine Preventive Medication

被引：0
|
作者：
McAllister, Peter [1 ]
Dodick, David [2 ]
Cohen, Joshua [3 ]
Yang, Ronghua [3 ]
Yeung, Paul [3 ]
Campos, Verena Ramirez [3 ]
机构：
[1] New England Inst Neurol & Headache, Stamford, CT USA
[2] Mayo Clin, Dept Neurol, Phoenix, AZ USA
[3] Teva Pharmaceut, Frazer, PA USA
来源：
NEUROLOGY | 2019年 / 92卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1.10-011
引用
收藏
页数：3
相关论文
共 50 条
  • [41] NUMBER NEEDED TO TREAT/HARM FOR FREMANEZUMAB IN PATIENTS WHO HAD INADEQUATE RESPONSE TO 2-4 PRIOR MIGRAINE PREVENTIVE MEDICATION CLASSES
    Ashina, Messoud
    Cohen, Joshua M.
    Galic, Maja
    Campos, Verena Ramirez
    Du, Evelyn
    Ning, Xiaoping
    Diener, Hans-Christoph
    [J]. CEPHALALGIA, 2020, 40 : 102 - 102
  • [42] COMPARATIVE COST-UTILITY ANALYSIS OF GALCANEZUMAB AND FREMANEZUMAB FOR MIGRAINE PREVENTION IN INDIVIDUALS WITH CHRONIC MIGRAINE WHO HAVE TRIED 2 TO 4 PRIOR PREVENTIVE TREATMENTS
    Bhardwaj, S.
    Zimmermann, M.
    Garrison, L.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S105 - S105
  • [43] Reduction in acute headache medication use with fremanezumab in chronic migraine patients by prior migraine preventive treatment use: Subgroup analysis of the HALO CM study
    Stark, R.
    Cohen, J. M.
    Yang, R.
    Ramirez-Campos, V.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [44] Health Care Utilization and Costs in Patients With Migraine Who Have Failed Previous Preventive Treatments
    Newman, Lawrence
    Vo, Pamela
    Zhou, Lujia
    Lopez, Cristina Lopez
    Cheadle, Andy
    Olson, Melvin
    Fang, Juanzhi
    [J]. NEUROLOGY-CLINICAL PRACTICE, 2021, 11 (03) : 206 - 215
  • [45] EFFICACY AND IMPACT ON ACUTE MEDICATION USE AND DISABILITY WITH FREMANEZUMAB IN PATIENTS WITH MIGRAINE WHO HAD INADEQUATE RESPONSE TO ≥3 PRIOR MIGRAINE PREVENTIVE MEDICATION CLASSES: RESULTS OF THE RANDOMIZED, DOUBLE-BLIND PHASE 3B FOCUS STUDY
    Lambru, Giorgio
    Dhiraj, Dalbir
    Ning, Xiaoping
    Campos, Verena Ramirez
    Du, Evelyn
    Cohen, Joshua M.
    Matharu, Manjit
    [J]. CEPHALALGIA, 2020, 40 : 91 - 92
  • [46] Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine
    Winner, Paul K.
    Spierings, Egilius L. H.
    Yeung, Paul P.
    Aycardi, Ernesto
    Blankenbiller, Tricia
    Grozinski-Wolff, Melissa
    Yang, Ronghua
    Ma, Yuju
    [J]. HEADACHE, 2019, 59 (10): : 1743 - 1752
  • [47] CLINICALLY RELEVANT REDUCTION OF MIGRAINE SYMPTOMS BY FREMANEZUMAB IN PATIENTS WITH UP TO ONE PREVENTIVE MIGRAINE PROPHYLAXIS TREATMENT IN THE PAST
    Caesar, M.
    Surmund, N.
    Schneller, S.
    Volmer, T.
    [J]. VALUE IN HEALTH, 2019, 22 : S738 - S738
  • [48] Efficacy of fremanezumab in patients with chronic and episodic migraine stratified by migraine frequency
    Nahas, Stephanie
    Ning, Xiaoping
    Campos, Verena Ramirez
    Barash, Steve
    Cohen, Joshua
    Silberstein, Stephen
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 216 - 217
  • [49] The impact of fremanezumab on medication overuse in patients with chronic migraine
    Silberstein, Stephen D.
    Ashina, Sait
    Katsarava, Zaza
    Bibeau, Kristen
    Seminerio, Michael J.
    Harlow, Danielle E.
    Cohen, Joshua M.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [50] The Impact of Fremanezumab on Medication Overuse in Patients with Chronic Migraine
    Silberstein, S. D.
    Ashina, S.
    Katsarava, Z.
    Bibeau, K.
    Seminerio, M. J.
    Harlow, D.
    Cohen, J. M.
    [J]. HEADACHE, 2018, 58 : 76 - 77
12345